Supplemental Material for “Sustained Multisite Response to Anifrolumab in Refractory Chilblain Lupus Erythematosus”

Name: Supplemental Material for “Sustained Multisite Response to Anifrolumab in Refractory Chilblain Lupus Erythematosus”
Creator: Sarah John
Published: 2026-08-24T13:29:04.592Z
Keywords: Immunology, Dermatology, Rheumatology, Systemic Lupus Erythematosus

John, Sarah; Scalzi, Lisabeth V.; Foulke, Galen; Helm, Matthew

doi:10.17632/78yp6vt6mh.2

Supplemental Material for “Sustained Multisite Response to Anifrolumab in Refractory Chilblain Lupus Erythematosus”

Published: 24 August 2026| Version 2 | DOI: 10.17632/78yp6vt6mh.2

Contributors:

Sarah John, Lisabeth V. Scalzi, Galen Foulke, Matthew Helm

Description

Invitae genetic testing panel results for the patient described in the case report, “Sustained Multisite Response to Anifrolumab in Refractory Chilblain Lupus Erythematosus.”

Files

Institutions

Penn State Milton S. Hershey Medical Center
Pennsylvania, Hershey

Supplemental Material for “Sustained Multisite Response to Anifrolumab in Refractory Chilblain Lupus Erythematosus”

Description

Files

Institutions

Categories

Licence